Marsal, J.
3648  Ergebnisse:
Personensuche X
?
1

P941 Observational study of tofacitinib in ulcerative colit..:

Nyberg, L ; Söderling, J ; Olén, O...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1713-i1714 , 2024
 
?
2

Real-World Outcomes of Patients Starting Intravenous and Tr..:

Lamichhane, N. ; Melas, N. ; Bergqvist, V....
Digestive Diseases and Sciences.  69 (2024)  6 - p. 2175-2183 , 2024
 
?
3

P1047 Observational study of tofacitinib in Ulcerative Coli..:

Nyberg, L ; Söderling, J ; Olén, O...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1887-i1889 , 2024
 
?
4

DOP79 Promising efficacy of biologicals and small molecules..:

Verstockt ., B ; Taelman, T ; Vavricka, S R...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i219-i221 , 2024
 
?
5

P219 Prognostic potential of mucosal proteins in Ulcerative..:

Salomon, B ; Carlson, M ; Bergemalm, D...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i549-i550 , 2024
 
?
6

P131 Is stress associated with subclinical inflammation in ..:

Borghede, M ; Marsal, J ; Faresjö, T.
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i295-i296 , 2023
 
?
 
?
10

Letter: how to define remission in ulcerative colitis – his..:

Angelison, L ; Marsal, J. ; Hertervig, E.
Alimentary Pharmacology & Therapeutics.  45 (2017)  8 - p. 1177-1178 , 2017
 
?
11

Long-term outcome of infliximab treatment in chronic active..:

Angelison, L. ; Almer, S. ; Eriksson, A....
Alimentary Pharmacology & Therapeutics.  45 (2016)  4 - p. 519-532 , 2016
 
1-15